Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM)
MIRM Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
13.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
41.80%
MIRM Stock Analysis
MIRM
PE Ratio:
MIRM
PEG Ratio:
Not Available
MIRM
Forward EPS Growth (12 month):
0.00%
MIRM
PS Ratio:
8.1
MIRM
PSG Ratio:
0.4
MIRM
Forward Revenue Growth (12 month):
20.30%
MIRM Articles
No data was found